Originally published as JCO Early Release 10.1200/JCO.2005.04.0014 on May 15 2006

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jagsi, R. Articles by Pierce, L. J. Search for Related Content PubMed PubMed Citation Articles by Jagsi, R. Articles by Pierce, L. J. Social Bookmarking                            What's this?

Stroke Rates and Risk Factors in Patients Treated With Radiation Therapy for Early-Stage Breast Cancer

Reshma Jagsi, Kent A. Griffith, Todd Koelling, Rachel Roberts, Lori J. Pierce

From the Radiation Oncology Department; University of Michigan Cancer Center Biostatistics Core; and the University of Michigan School of Medicine, Internal Medicine Department, Ann Arbor, MI

Address reprint requests to Lori J. Pierce, MD, Department of Radiation Oncology, University of Michigan School of Medicine, 4308 Cancer and Geriatrics Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109-0010; e-mail: ljpierce{at}umich.edu

PURPOSE: To examine whether stroke risk is elevated in American breast cancer patients treated with modern techniques, as well as whether supraclavicular radiation therapy (RT) is associated with increased risk.

METHODS: Observed rates of stroke in 820 eligible early-stage breast cancer patients treated at the University of Michigan Hospital (Ann Arbor, MI) were compared with expected rates. Relationships between potential risk factors and actuarial rate of first stroke were analyzed.

RESULTS: Median follow-up was 6.8 years. Twenty patients had at least one cerebrovascular accident (CVA) in follow-up; 35 patients had at least one CVA or transient ischemic attack (CVA/TIA). The standardized incidence ratios were 1.74 (0.94 to 2.37) for CVA and 1.68 (1.003 to 2.06) for CVA/TIA. The absolute excess risk per 1,000 patients per year was 1.67 for CVA and 2.76 for CVA/TIA. On bivariate analysis, factors significantly associated with actuarial rate of first CVA included hypertension (P = .002), age (P < .0001), coronary artery disease (P = .001), atrial fibrillation (P = .009), and supraclavicular RT (P = .021). Factors associated with CVA/TIA were hypertension (P < .001), coronary artery disease (P = .002), and age (P < .0001). Tamoxifen use alone was not significant (P = .19), but tamoxifen combined with baseline hypertension led to increased risk of CVA/TIA (log-rank P < .0001). On multivariate analysis, only age (P < .001) and hypertension (P = .003) remained significant predictors of CVA/TIA. Age was the only significant predictor of CVA alone (P < .001).

CONCLUSION: American breast cancer survivors may have an elevated risk of stroke compared with the general population, but the absolute excess risk is low. This study found no significant association between supraclavicular RT and stroke after controlling for other factors.

Presented in abstract form at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 8-12, 2005.

The authors certify that this is an original unpublished work.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. J. Hooning, L. D.A. Dorresteijn, B. M.P. Aleman, A. C. Kappelle, J. G.M. Klijn, W. Boogerd, and F. E. van Leeuwen Decreased Risk of Stroke Among 10-Year Survivors of Breast Cancer J. Clin. Oncol., December 1, 2006; 24(34): 5388 - 5394. [Abstract] [Full Text] [PDF]